간편하게 보는 뉴스는 유니콘뉴스
Bio-Gene and Envu Collaborate to Evaluate Flavocide™ for Use in Public and Private Sector Mosquito Management

· 등록일 Aug. 15, 2024 10:25

· 업데이트일 2024-08-16 00:00:29

MELBOURNE, AUSTRALIA & CARY, N.C.--(Business Wire / Korea Newswire)--Bio-Gene Technology Limited (ASX:BGT or ‘Bio-Gene’), an Australian company developing the next generation of novel bio-insecticides, and Envu are evaluating Flavocide™ for use in professional pest management and public health products to control mosquitoes.

Vector-borne diseases account for more than 17% of all infectious diseases, causing more than 700 000 deaths annually. They can be caused by either parasites, bacteria or viruses. Malaria is a parasitic infection transmitted by Anopheline mosquitoes. It causes an estimated 219 million cases globally, and results in more than 400,000 deaths every year. Most of the deaths occur in children under the age of 5 years. (Photo: Business Wire) Envu, a global company dedicated to environmental science, develops innovative solutions to manage insects, weeds and turf diseases that threaten public health and environments. Through its ESG pillars, Envu is committed to nature-positive innovation. As a nature-identical compound, Flavocide complements the company’s professional pest and mosquito management product portfolios.

This collaboration combines Bio-Gene’s discovery and development pipeline with the formulation expertise of Envu to maximize efficacy and application efficiency. Bio-Gene and Envu have successfully evaluated several formulations of Flavocide to target mosquitoes and will continue to evaluate Flavocide for a range of professional use products to control these public health pests.

Tim Grogan, Managing Director & Chief Executive Officer for Bio-Gene said: “Our work with Envu extends the potential for Flavocide to be used in major professional pest management and public health target markets worldwide for the control of mosquitoes. Envu is a world leader in the commercial development and marketing of new and sustainable products to combat mosquitoes. This important program supports our strategy of engaging with a range of strong partners to fully exploit the opportunities available for our technologies.”

Bernard Jacqmin, Senior Vice President - Head of Global Innovation for Envu said: “We are pleased to be working with Bio-Gene and to formulate and evaluate Flavocide for use in mosquito management applications. Flavocide is derived from nature and, based on our testing completed to date, has demonstrated a favorable profile to combat mosquitoes. Our combined efforts are already showing promising results in the testing phase, and we are excited about the potential benefits for consumers and professionals in the field.”

Flavocide is a nature-identical product based on Flavesone, a naturally occurring plant compound present in some eucalypts. Bio-Gene has developed a proprietary process to synthesize the molecule and produce it in commercial quantities.

Flavocide exhibits a new mode of action - that is, the way an insecticide controls or knocks down an insect - and is able to overcome insect resistance to current insecticidal products. Mosquito strains can become particularly resistant to existing products, making it challenging to manage the spread of serious diseases such as Malaria, Dengue fever and Zika virus. Insecticides with new modes of action are rare and are essential to ensure future global food security and public health.

Bio-Gene is developing Flavocide to address the major worldwide problem of insecticide resistance in the areas of public health, crop protection, grain storage and consumer applications.

At this time, Bio-Gene and Envu are exploring opportunities for Envu to use Flavocide in commercial product(s). Any future development or licensing agreements will be jointly announced by Bio-Gene and Envu.

Approved for release by Bio-Gene and by Envu.

About Bio-Gene Technology Limited

Bio-Gene is an Australian company developing novel bio-insecticides to address the global challenges of insecticide resistance and toxicity. Its unique products are based on a naturally occurring class of compounds proven to overcome resistance to control pests with minimal impact on human health and the environment.

Bio-Gene’s products have multiple applications across crop protection, grain storage, public health and consumer uses. They provide new options derived from nature to meet market demand for effective and safe pest management solutions.

Flavocide™ is a trademark of Bio-Gene Technology Limited.

About Envu

Envu was founded in 2022, a company built on years of environmental science experience, for the sole purpose of advancing healthy environments for everyone, everywhere. Envu offers dedicated services in: Professional Pest Management, Forestry, Ornamentals, Golf, Industrial Vegetation Management, Lawn & Landscape, Mosquito Management, and Range & Pasture. Envu collaborates with customers to design innovative solutions that meet their requirements today and well into the future. The Envu portfolio consists of over 180 trusted and well-known brands. The company employs 900 people, operates in 100 countries and has four global innovation hubs. For additional information, visit www.envu.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240813495113/en/

Website: https://bio-gene.com.au/ Contact Bio-Gene
Investor Relations
Adrian Mulcahy
0438-630-422
[email protected]

Media Relations
Tristan Everett
0403-789-096
[email protected]

Envu
Jennifer Poore
Head of Corporate Communications
+011-1-919-475-5814
[email protected]
This news is a press release provided by Bio-Gene Technology Limited. Korea Newswire follows these editorial guidelines. Bio-Gene Technology Limited News ReleasesSubscribeRSS 바이오-진과 엔뷰, 공공 및 민간 부문 모기 관리에 사용하기 위한 플라보사이드™를 평가하기 위해 협력 차세대 신종 바이오 살충제를 개발하는 호주 회사인 바이오-진 테크놀로지(Bio-Gene Technology Limited)(ASX:BGT 또는 ‘Bio-Gene’)와 엔뷰(Envu)가 전문 해충 관리 및 모기 방제를 위한 공중 보건 제품에 사용하기 위해 플라보사이드™(Flavocide™)를 평가하고 있다. 환경 과학에 전념하는 글로벌 기업인 엔뷰... 8월 15일 10:25 More News Health Infection Control Alliance Overseas Bio-Gene Technolo... All News Releases 
배포 분야
인기 기사12.23 13시 기준
부산--(뉴스와이어)--부산 사하구의 대표 디지털 체험공간 ‘빛담디지털라운지’에 나만의 추억을 저장해보자. 부산 사하구의 대표 디지털 체험공간 ‘빛담디지털라운지’에 오픈한 소원을 담는 타임캡슐 나무 ‘소담나무’ ...
군산--(뉴스와이어)--아티클21 유한책임회사(대표 오아름)는 20일 전라북도사회적경제혁신타운에서 유한회사 새만금그린푸드(대표 한광자)와 지식 재산(IP)을 활용한 상품 개발 및 마케팅을 위한 업무 협약식을 진행했다고 밝혔다. 아티클21-새만금그린푸드 양해 각서 체결식 ...
서울--(뉴스와이어)--한화그룹이 사업군별 선택과 집중을 위해 일부 사업부에 대한 계열사 간 스몰딜을 추진한다. 한화의 일부 사업을 한화오션과 한화솔루션에 양도하고 모멘텀 부문을 물적분할하는 사업구조 개편을 단행한다. 한화그룹...
서울--(뉴스와이어)--미래에셋생명은 ‘암 걱정없는 암치료보험(갱신형) 무배당’을 4일 출시했다고 밝혔다. 이번 신상품은 기존 헬스케어 암보험의 주 콘셉트인 올-케어 보장을 한층 더 업그레이드시켜 암치료 여정 전반의 보장을 빈틈없이 채워줄 신개념 암치료 보험을 지향한다. 또한, 대부분 보험상품이 공급자...
서울--(뉴스와이어)--친환경 열분해 기술 선도 기업 에코크레이션(대표 전범근)은 환경부와 환경산업기술원이 주관하는 ‘필리핀 바타안주 해양 플라스틱 저감관리 마스터 플랜 실증사업’에 참여한다고 8일 밝혔다. 에코크레이션 사옥 전경 ...
DALLAS--(Business Wire / Korea Newswire)--Mary Kay Inc., a global leader in women’s empowerment, today announced the release of a special report titled “Advancing Women’s Entrepreneurship: from Commitment to Action.” The report details the company’s...
API
fg
유니콘뉴스는 보도자료 배포 서비스입니다.
여기에 뉴스를 등록하면 언론이 보도하고 널리 배포됩니다.